Latest News
14 October 2024
Dr. Marcos Malumbres receives a CaixaImpulse grant to develop a new generation of drugs against liver cancer
From the laboratory to the patient: the ”la Caixa” Foundation promotes 29 biomedicine and health projects The ”la Caixa” Foundation...
10 October 2024
The Paseíco de la Mama 2024 will support the INSP3KTION project
The 14th edition of the solidarity initiative, the Paseíco de la Mama, took place on 28 September. A historic initiative...
08 October 2024
Elena Garralda’s post-ESMO Congress 2024 column: The expanding toolbox for immuno-oncology
In her latest On target column published by the ESMO Daily Reporter, VHIO’s Elena Garralda discusses the expanding toolbox for immuno-oncology in advanced...
07 October 2024
Exploring predictive biomarkers of response and resistance to targeted therapy in BRAF-mutated metastatic colorectal cancer
The phase 3 BEACON CRC trial demonstrated that treatment with the BRAF inhibitor encorafenib plus anti-EGFR monoclonal antibody cetuximab, with...
Research Programs
PRECLINICAL & TRANSLATIONAL RESEARCH
Cellular Plasticity and Cancer Group
Our group focuses on the interplay between cellular plasticity, stem cells and cancer. Cellular plasticity is recognized today as a critical feature of cancer cells that enables them to transit between different cellular states, including reversible transitions.
PRECLINICAL & TRANSLATIONAL RESEARCH
Growth Factors Group
We focus our research on mechanisms of resistance to targeted therapies and most importantly, how to overcome it by showing that breast cancers resistant to T-DM1, an antibody-drug conjugate ADC)- can be efficiently treated with the second generation ADC SYD985 (Nadal-Serrano et al.).
CORE TECHNOLOGIES
Cancer Genomics Group
VHIO’s Cancer Genomics Group serves as a Core Technology laboratory. We are also dedicated to translational research as well as the development of novel genomic tests.
RESEARCHERS
Events
Saturday 30 November 24 - 08:00 AM
Clinical Trials Training Course in Oncology and Hematology
Friday 29 November 24 - 01:00 PM
Clinical Trials Training Course in Oncology and Hematology
Tuesday 26 November 24 - 08:00 AM
PRECEPTORSHIP HEREDITARY CANCER 2024
Saturday 23 November 24 - 08:00 AM
Clinical Trials Training Course in Oncology and Hematology
